Translational Research in Functional Vision and Accessibility

项目总结/摘要 该提案要求部分支持召开一次关于转化研究最新技术及其应用的会议。 应用于视力受损者的功能性视觉和盲人的无障碍环境。裁谈会 由史密斯-凯特尔韦尔眼科研究所的科学家组织，将于2023年8月3日至4日举行 在加利福尼亚州的旧金山弗朗西斯科。为了与本次会议以转化研究为中心的独特主题保持一致， 为了优化功能的视觉和可访问性，我们的目标包括整合多学科的方法， 评估视觉功能障碍及其后果。第二个目标是让利益相关者（那些经历过 视力丧失和失明）和那些做转化研究的人（科学家，临床医生和发明家）， 优先考虑未来诊断和治疗/干预的研究方向。这个的一个特点是 会议将考虑从视觉障碍到失明的范围，并评估相对的 最大限度地提高残余视力、视力恢复和使用剩余感官进行访问的优点 来自环境的信息。该计划将包括6个会议，和1个双倍长度的会议，超过两个 共有40位发言人。每次会议将包括一系列发言者从建立研究人员 包括多个利益相关者。多样性和包容性将被优先考虑，包括 妇女、残疾人和代表性不足的少数群体。每节课将以讨论结束 科学家、临床医生和利益相关者之间的对话，由史密斯-凯特尔韦尔科学家主持。所有讲座 将提供无障碍演示，让视力和听力受损的与会者充分参与。我们 我计划使口头报告混合，以最大限度地扩大本次会议的影响，并提供20个旅行 鼓励受训人员参加的研究金。海报会议将促进科学交流和指导 在参与者中。总之，这次独特的会议汇集了多学科，跨领域的方法， 解决视觉功能障碍的多种原因和目前的治疗方式，以及一个整体的 评估最佳干预措施的方法，以最大限度地提高盲人与环境的相互作用 和视力受损。

PROJECT SUMMARY/ABSTRACT This proposal requests partial support for a conference on the state of the art in translational research and its application to functional vision for the visually impaired and accessibility for the blind. The conference is organized by the scientists at the Smith-Kettlewell Eye Research Institute and will take place August 3-4, 2023 in San Francisco, CA. In keeping with the unique theme of this conference centered on translational research to optimize functional vision and accessibility, our aims include integrating multi-disciplinary approaches to evaluating visual dysfunction and its consequences. A second aim is to bring stakeholders (those experiencing vision loss and blindness) and those doing translational research (scientists, clinicians, and inventors) to prioritize future research directions for diagnosis and treatment/interventions. A special feature of this conference will be to consider the spectrum from visual impairment to blindness and evaluate the relative merits of maximizing residual vision, visual restoration and the use of remaining senses for accessing information from the environment. The program will include 6 sessions, and 1 double-length session, over two days, with a total of 40 speakers. Each session will include a range of speakers from established researchers to junior investigators, including multiple stakeholders. Diversity and inclusion will be prioritized to include women, individuals with disability and underrepresented minorities. Each session will end with a discussion between scientists, clinicians and stakeholders, moderated by a Smith-Kettlewell scientist. All talk sessions will have accessible presentations to allow full participation by visually and hearing-impaired attendees. We plan to make the oral presentations hybrid to maximize the reach of this conference and offer 20 travel fellowships to encourage trainees to attend. Poster sessions will facilitate scientific exchange and mentoring among participants. In sum, this unique conference brings together multidisciplinary, cross-cutting approaches to address the multiple causes of vision dysfunction and current treatment modalities, as well as a holistic approach to evaluating the best interventions to maximize interaction with the environment among the blind and visually impaired.